<!doctype html><html lang=cn><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><meta name=referrer content="no-referrer"><link rel=dns-prefetch href=https://i.geekbank.cf/><title>SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用 | 极客快訊</title><meta property="og:title" content="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用 - 极客快訊"><meta property="og:type" content="article"><meta property="og:locale" content="cn"><meta property="og:image" content="https://p3.pstatp.com/large/pgc-image/70ac3fd9437640c68f63b742d73fd752"><link rel=alternate hreflang=x-default href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/73c2479.html><link rel=alternate hreflang=zh-tw href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/73c2479.html><link rel=alternate hreflang=zh-cn href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%a6/73c2479.html><link rel=alternate hreflang=zh-hk href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/73c2479.html><link rel=alternate hreflang=zh-mo href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/73c2479.html><link rel=alternate hreflang=zh-my href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%a6/73c2479.html><link rel=alternate hreflang=zh-sg href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%a6/73c2479.html><link rel=canonical href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/73c2479.html><meta property="article:published_time" content="2020-10-29T20:57:49+08:00"><meta property="article:modified_time" content="2020-10-29T20:57:49+08:00"><meta name=Keywords content><meta name=description content="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用"><meta name=author content="极客快訊"><meta property="og:url" content="/cn/%E7%A7%91%E5%AD%A6/73c2479.html"><link rel=apple-touch-icon sizes=180x180 href=../../apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=../../favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=../../favicon-16x16.png><link rel=manifest href=../../site.webmanifest><link rel=mask-icon href=../../safari-pinned-tab.svg color=#5bbad5><meta name=msapplication-TileColor content="#ffc40d"><meta name=theme-color content="#ffffff"><link rel=stylesheet href=https://geekbank.cf/css/normalize.css><link rel=stylesheet href=https://geekbank.cf/css/style.css><script type=text/javascript src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js></script><script type=text/javascript src=https://geekbank.cf/js/jqthumb.min.js></script><script data-ad-client=ca-pub-3525055026201463 async src=https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js></script></head><body><header id=header class=clearfix><div class=container><div class=col-group><div class=site-name><h1><a id=logo href>🤓 极客快讯 Geek Bank</a></h1><p class=description>为你带来最全的科技知识 🧡</p></div><div><nav id=nav-menu class=clearfix><a class=current href>猜你喜歡</a>
<a href=../../tw/categories/%E7%A7%91%E6%8A%80.html title=科技>科技</a>
<a href=../../tw/categories/%E9%81%8A%E6%88%B2.html title=遊戲>遊戲</a>
<a href=../../tw/categories/%E7%A7%91%E5%AD%B8.html title=科學>科學</a></nav></div></div></div></header><div id=body><div class=container><div class=col-group><div class=col-8 id=main><div class=res-cons><article class=post><header><h1 class=post-title>SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用</h1></header><date class="post-meta meta-date">2020-10-29</date><div class=post-meta><span>|</span>
<span class=meta-category><a href=cn/categories/%E7%A7%91%E5%AD%A6.html>科学</a></span></div><div class=post-content><p><br></p><p>糖尿病是因胰岛素分泌绝对不足或相对不足，引起渐进性糖、脂肪、蛋白质、水和电解质紊乱的疾病，以高血糖为主要标志，可分为 1 型糖尿病、2 型糖尿病、妊娠糖尿病（GDM）和特殊类型糖尿病 4 类。</p><p>动脉粥样硬化性心血管疾病（ASCVD）和/或慢性肾脏疾病（CKD）是 2 型糖尿病（T2DM）常见合并疾病及致残和致死的首要原因。新型降糖药物钠-葡萄糖共转运蛋白 2（SGLT-2）抑制剂、胰高糖素样肽 1（GLP-1）受体激动剂可显著改善心血管和肾脏结局，那么临床如何使用呢？</p><p><strong>一、SGLT-2 抑制剂和 GLP-1 受体激动剂的比较</strong></p><p>SGLT-2 抑制剂和 GLP-1 受体激动剂均有利尿、排钠、减轻体重、降低血压和减轻血管炎症的作用。</p><p>（1）SGLT-2 抑制剂</p><p>SGLT-2 抑制剂为口服类降糖药物，如达格列净、恩格列净和卡格列净，通过抑制肾脏近曲小管重吸收葡萄糖的 SGLT-2 活性，增加尿液中葡萄糖排泄而降糖，其降糖作用呈血糖水平依赖性，降糖疗效近似于二甲双胍而优于磺脲类药物及 DPP-4 抑制剂，并增加水钠和尿酸的排出，且减少内脏脂肪（对骨骼肌影响小）、减轻体重和降低血压，还可降低血容量、提高射血分数、增加心脏能量底物（酮体，游离脂肪酸）。</p><p>SGLT-2 抑制剂单独使用时不增加或极少致低血糖风险，联合胰岛素或胰岛素促泌剂（如磺脲类药物和格列脲类药物）时，可增加低血糖发生风险。</p><div class=pgc-img><img alt="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用" onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/70ac3fd9437640c68f63b742d73fd752><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><p>（2）GLP-1 受体激动剂</p><p>GLP-1 受体激动剂主要是注射类降糖药物，如利拉鲁肽、司美鲁肽、度拉糖肽，均需皮下注射，司美鲁肽有口服制剂。</p><p>其通过激活体内 GLP-1 受体发挥降糖效应，以葡萄糖浓度依赖的方式增强胰岛素分泌及抑制胰高糖素分泌，并可延缓胃排空、抑制食欲中枢减少进食量，同时可有效降低空腹和餐后血糖、降低体重/血压/甘油三酯，更适于胰岛素抵抗、腹型肥胖的糖尿病者。</p><p>与磺脲类药物、噻唑烷二酮类（TZDs）药物及甘精胰岛素相比，GLP-1 受体激动剂有更强或相当的降低 HbA1C 的能力，但其降体重效果明显优于以上药物。GLP-1 受体激动剂单独使用极少增加低血糖发生的风险。</p><p></p><div class=pgc-img><img alt="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用" onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/5f484c1f5d1448b9a4eab1868105daab><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><div class=pgc-img><img alt="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用" onerror=errorimg.call(this); src=https://p9.pstatp.com/large/pgc-image/3d27f7cbf16f474ba98b2f0b016633f3><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><div class=pgc-img><img alt="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用" onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/d8f275ee2b7c403caef77ddc450db201><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><p><strong>二、SGLT-2抑制剂和GLP-1受体激动剂的选用</strong></p><p>SGLT-2 抑制剂对合并 ASCVD 或心血管高风险因素的 T2DM 者，有明确的改善心血管结局的作用，其中对心力衰竭的改善尤为突出，同时对肾脏有保护作用。GLP-1 受体激动剂对 T2DM 合并 ASCVD 或危险因素者，能延缓心血管疾病和肾脏疾病的进展，保护心脑血管及肾脏。</p><div class=pgc-img><img alt="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用" onerror=errorimg.call(this); src=https://p9.pstatp.com/large/pgc-image/d7eb551accf44614b9bb95431540bfb9><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><div class=pgc-img><img alt="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用" onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/b32964e0a25e4086a1bc0def32dea5e8><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><div class=pgc-img><img alt="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用" onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/b7304b91ba3a4c3aba033876359404e4><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><p><strong>三、SGLT-2 抑制剂和 GLP-1 受体激动剂使用的注意事项</strong></p><p>SGLT-2 抑制剂和 GLP-1 受体激动剂安全性和耐受性好，但在使用过程中仍应注意相关不良反应与用药禁忌。</p><div class=pgc-img><img alt="SGLT-2 抑制剂和 GLP-1 受体激动剂的区别与选用" onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/4342a182f74b4caf95c6c6e4f5ec68e6><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p></div><div class="post-meta meta-tags"><ul class=clearfix><li><a>'SGLT','GLP','受体'</a></li></ul></div></article></div></div><div id=secondary><section class=widget><form id=search action=//www.google.com/search method=get accept-charset=utf-8 target=_blank _lpchecked=1><input type=text name=q maxlength=20 placeholder=搜索>
<input type=hidden name=sitesearch value=geekbank.cf>
<button type=submit>🔍</button></form></section><section class=widget><h3 class=widget-title>最新文章 ⚡</h3><ul class=widget-list></ul></section><section class=widget><h3 class=widget-title>其他</h3><ul class=widget-list><li><a href=TOS.html>使用條款</a></li><li><a href=CommentPolicy.html>留言政策</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>DMCA</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>聯絡我們</a></li></ul></section></div></div></div></div><footer id=footer><div class=container>&copy; 2020 <a href>极客快訊</a></div></footer><script type=text/javascript>window.MathJax={tex2jax:{inlineMath:[['$','$']],processEscapes:true}};</script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-MML-AM_CHTML" async></script><a id=rocket href=#top></a><script type=text/javascript src=https://kknews.cf/js/totop.js async></script><script type=application/javascript>var doNotTrack=false;if(!doNotTrack){window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date;ga('create','UA-146415161-2','auto');ga('send','pageview');}</script><script async src=https://www.google-analytics.com/analytics.js></script><script type=text/javascript src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5e508ed9e4e698bb"></script></body></html>